- Home
- ZLAB vs RQI Comparison
ZLAB vs RQI Comparison
Compare ZLAB & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | RQI |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | RQI |
|---|---|---|
| Price | $18.31 | $12.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $49.60 | N/A |
| AVG Volume (30 Days) | 714.0K | ★ 898.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.20% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $26.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $11.30 |
| 52 Week High | $39.64 | $13.57 |
Technical Indicators
Market Signals| Indicator | ZLAB | RQI |
|---|---|---|
| Relative Strength Index (RSI) | 39.86 | 56.96 |
| Support Level | $16.84 | $12.12 |
| Resistance Level | $19.55 | $13.47 |
| Average True Range (ATR) | 0.76 | 0.15 |
| MACD | -0.25 | 0.07 |
| Stochastic Oscillator | 4.64 | 80.99 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. The Fund's secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.